Prestige Consumer Healthcare (PBH) Deferred Taxes (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Deferred Taxes of $3.6 million in Q4 2025, down 79.31% quarter-over-quarter from $17.4 million in Q3 2025, and up 23.44% on a YoY basis from $2.9 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Deferred Taxes (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Deferred Taxes history runs 16 years deep, the most recent figure standing at $3.6 million for Q4 2025.
- In Q4 2025, Deferred Taxes rose 23.44% year-over-year to $3.6 million; the TTM figure through Dec 2025 stood at $33.9 million (up 119.58% YoY), while the FY2025 annual figure was $14.4 million, down 37.54% from the prior year.
- Deferred Taxes was $3.6 million for Q4 2025 at Prestige Consumer Healthcare, down from $17.4 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $17.4 million in Q3 2025 to a low of -$74.8 million in Q1 2023.
- Historically, Deferred Taxes has averaged $1.2 million across 5 years, with a median of $4.0 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Deferred Taxes slumped 5578.51% in 2023, then jumped 852.12% in 2025.
- A 5-year view of Deferred Taxes shows it stood at $3.7 million in 2021, then soared by 168.25% to $9.8 million in 2022, then tumbled by 47.29% to $5.2 million in 2023, then sank by 43.65% to $2.9 million in 2024, then grew by 23.44% to $3.6 million in 2025.
- The last three Deferred Taxes figures came in at $3.6 million (Q4 2025), $17.4 million (Q3 2025), and $5.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -22.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 34.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 25.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 14,341.73 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -61.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -8.79 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -13.98 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 19.33 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | 3.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.60 Mn |
| Sep 30, 2025 | 17.38 Mn |
| Jun 30, 2025 | 5.83 Mn |
| Mar 31, 2025 | 7.13 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Sep 30, 2024 | 3.75 Mn |
| Jun 30, 2024 | 612,000.00 |
| Mar 31, 2024 | 8.18 Mn |
| Dec 31, 2023 | 5.17 Mn |
| Sep 30, 2023 | 5.45 Mn |
| Jun 30, 2023 | 4.27 Mn |
| Mar 31, 2023 | -74.79 Mn |
| Dec 31, 2022 | 9.81 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | -1.32 Mn |
| Dec 31, 2021 | 3.66 Mn |
| Sep 30, 2021 | 1.76 Mn |
| Jun 30, 2021 | 5.88 Mn |
| Mar 31, 2021 | 10.66 Mn |